Loading...
Market
Will the DEA classify protonitazene as Schedule I by end of 2024?
4
Resolution / Starting Odds
Yes • 50%
No • 50%
DEA official announcements or updates to the Controlled Substances Act
Story
Synthetic Opioid Three Times More Powerful Than Fentanyl Linked to California Overdose Death
Nov 23, 2024, 12:46 AM
A synthetic opioid known as protonitazene, which is up to three times more powerful than fentanyl, has been linked to a recent overdose death in California. This incident has prompted the U.S. Department of Justice's Los Angeles office to file charges in what could be the nation's first death-resulting criminal case involving the drug. Federal prosecutors have noted that protonitazene is several times stronger than fentanyl. The growing potency and danger of synthetic opioids like protonitazene highlight the escalating opioid crisis in the United States.
View original story
Similar markets
Remain Schedule I • 25%
Rescheduled to Schedule II • 25%
Rescheduled to Schedule III • 25%
Rescheduled to Schedule IV or V • 25%
Marijuana rescheduled to Schedule II • 25%
Marijuana rescheduled to Schedule III • 25%
Marijuana rescheduled to Schedule IV • 25%
No rescheduling • 25%
Descheduled • 25%
Rescheduled to a lower schedule • 25%
Remains schedule I • 25%
Other • 25%
Approved without restrictions • 25%
Approved with restrictions • 25%
Not approved • 25%
Decision delayed • 25%
Approval without restrictions • 25%
Approval with restrictions • 25%
Request for more data • 25%
Rejection • 25%
Approved without restrictions • 25%
Approved with restrictions • 25%
Rejected • 25%
Decision delayed • 25%